{"id":241035,"date":"2025-08-08T19:37:45","date_gmt":"2025-08-08T17:37:45","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=241035"},"modified":"2025-08-08T19:37:48","modified_gmt":"2025-08-08T17:37:48","slug":"fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/","title":{"rendered":"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis"},"content":{"rendered":"\n<p><strong>Barcelona, 8 d\u2019agost de 2025.<\/strong>\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el<strong><em><span style=\"text-decoration: underline\"><a href=\"https:\/\/fefac.cat\/empresarial\/comunicat-oficial-fefac-cas-ima-contigo\/\"> posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health<\/a><\/span><\/em><\/strong>, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.<\/p>\n\n\n\n<p>En aquest comunicat, FEFAC va subratllar la import\u00e0ncia d\u2019actuar amb prud\u00e8ncia fins a haver estudiat la sent\u00e8ncia, i de basar qualsevol valoraci\u00f3 en resolucions judicials fermes i en la normativa vigent, aix\u00ed com la necessitat de protegir tant el model farmac\u00e8utic com la seguretat del pacient.<\/p>\n\n\n\n<p>La comunicaci\u00f3 oficial de l\u2019AEMPS aclareix que:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>La sent\u00e8ncia esmentada a la premsa es limita a un procediment sancionador concret i no anul\u00b7la la resoluci\u00f3 de 5 de juliol de 2022 que, centrant-se en el fons, va ordenar la interrupci\u00f3 del servei d\u2019IMA Health.<\/li>\n\n\n\n<li>La Sent\u00e8ncia del Tribunal Suprem n\u00fam. 961\/2025 estableix una doctrina clara i vinculant sobre la il\u00b7legalitat dels serveis d\u2019intermediaci\u00f3 en la venda a dist\u00e0ncia de medicaments, especialment amb recepta m\u00e8dica.<\/li>\n\n\n\n<li>L\u2019AEMPS mant\u00e9 el seu criteri, tal com va fer FEFAC en la seva primera notificaci\u00f3, i anuncia que iniciar\u00e0 actuacions contra aquestes plataformes i contra les farm\u00e0cies que hi participin.<\/li>\n<\/ul>\n\n\n\n<p>Aquests punts evidencien que FEFAC va actuar des del primer moment amb prud\u00e8ncia i responsabilitat, ajustant la seva an\u00e0lisi i posicionament als criteris expressats per la m\u00e0xima autoritat reguladora en medicaments a Espanya.<\/p>\n\n\n\n<p>FEFAC continuar\u00e0 vetllant per la defensa de la legalitat, la seguretat del pacient i la sostenibilitat del model de farm\u00e0cia comunit\u00e0ria, actuant sempre amb la responsabilitat i la transpar\u00e8ncia que ens caracteritza.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Barcelona, 8 d\u2019agost de 2025.\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.<\/p>\n","protected":false},"author":2313,"featured_media":224377,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2066,2067,10,11,12,13,14,15,297,251],"tags":[387,2485],"class_list":["post-241035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-notes-premsa","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-fefac-actua","category-reflexions-de-junta","tag-departament-de-salut","tag-ima-contigo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis - FEFAC<\/title>\n<meta name=\"description\" content=\"Barcelona, 8 d\u2019agost de 2025.\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis - FEFAC\" \/>\n<meta property=\"og:description\" content=\"Barcelona, 8 d\u2019agost de 2025.\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-08T17:37:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-08T17:37:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"230\" \/>\n\t<meta property=\"og:image:height\" content=\"160\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis\",\"datePublished\":\"2025-08-08T17:37:45+00:00\",\"dateModified\":\"2025-08-08T17:37:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/\"},\"wordCount\":345,\"commentCount\":2,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"keywords\":[\"Departament de Salut\",\"IMA Contigo\"],\"articleSection\":[\"Actualitat\",\"Notes de premsa\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"FEFAC Actua\",\"Reflexions de Junta\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/\",\"name\":\"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"datePublished\":\"2025-08-08T17:37:45+00:00\",\"dateModified\":\"2025-08-08T17:37:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"Barcelona, 8 d\u2019agost de 2025.\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/logo-fefac-notis.jpg\",\"width\":230,\"height\":160},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis - FEFAC","description":"Barcelona, 8 d\u2019agost de 2025.\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/","og_locale":"ca_ES","og_type":"article","og_title":"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis - FEFAC","og_description":"Barcelona, 8 d\u2019agost de 2025.\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.","og_url":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/","og_site_name":"FEFAC","article_published_time":"2025-08-08T17:37:45+00:00","article_modified_time":"2025-08-08T17:37:48+00:00","og_image":[{"width":230,"height":160,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis","datePublished":"2025-08-08T17:37:45+00:00","dateModified":"2025-08-08T17:37:48+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/"},"wordCount":345,"commentCount":2,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","keywords":["Departament de Salut","IMA Contigo"],"articleSection":["Actualitat","Notes de premsa","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","FEFAC Actua","Reflexions de Junta"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/","url":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/","name":"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","datePublished":"2025-08-08T17:37:45+00:00","dateModified":"2025-08-08T17:37:48+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"Barcelona, 8 d\u2019agost de 2025.\u2013 La Federaci\u00f3 d\u2019Associacions de Farm\u00e0cies de Catalunya (FEFAC) vol destacar que el comunicat em\u00e8s ahir per l\u2019Ag\u00e8ncia Espanyola de Medicaments i Productes Sanitaris (AEMPS), dif\u00f3s a trav\u00e9s del Consejo General de Colegios Oficiales de Farmac\u00e9uticos (CGCOF), confirma el posicionament inicial que la nostra entitat va fer p\u00fablic de manera immediata el passat 5 d\u2019agost en relaci\u00f3 amb el cas IMA Health, amb la voluntat de transmetre la serenor necess\u00e0ria en moments d\u2019incertesa i comunicacions per part d\u2019interessats.","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2020\/06\/logo-fefac-notis.jpg","width":230,"height":160},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/fefac-referma-la-seva-postura-en-el-cas-ima-health-i-veu-avalades-les-seves-analisis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"FEFAC referma la seva postura en el cas IMA Health i veu avalades les seves an\u00e0lisis"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/241035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=241035"}],"version-history":[{"count":1,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/241035\/revisions"}],"predecessor-version":[{"id":241036,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/241035\/revisions\/241036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/224377"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=241035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=241035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=241035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}